News
Videos
Conferences
Events
Resources
Subscribe

|Videos|August 19, 2016

Melanoma Education and Support

Episodes in this series

EP. 1 The Mission of Mollie's Fund

EP. 1 The Mission of Mollie's Fund

EP. 2 Misconceptions About Melanoma

EP. 2 Misconceptions About Melanoma

EP. 3 Melanoma Education and Support

EP. 3 Melanoma Education and Support

EP. 4 Sun Tanning Alternatives

EP. 4 Sun Tanning Alternatives

EP. 5 Sun Safety and Self-Exams

EP. 5 Sun Safety and Self-Exams

EP. 6 Accomplishments and Moving Forward

EP. 6 Accomplishments and Moving Forward

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Visal Patel

What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma

BySpencer Feldman

October 9th 2025

Image of FDA.

FDA Approves Libtayo for Cutaneous Squamous Cell Carcinoma Treatment

October 8th 2025

CPAN begins the fourth quarter with a continued focus on its core mission: © stock.adobe.com.

2025 Quarter 3 – COA Patient Advocacy Network News Bulletin

By COA Patient Advocacy Network

October 2nd 2025

You don’t want to miss the upcoming CPAN Advocacy Chat, we hope you can join us!: © stock.adobe.com.

How PBMs Are Blocking Patient Access to Medication: A CPAN Advocacy Chat

By COA Patient Advocacy Network

October 2nd 2025

Non-melanoma skin cancer is a common and highly treatable type of cancer that originates in the top layer of the skin.

Non-Melanoma Skin Cancer: An Overview From Diagnosis to Treatment

September 19th 2025

Trending on CURE

What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?

Body Image and Sexual Health Challenges After Breast Cancer

FDA Grants Fast Track Designation to ADCE-D01 for Soft Tissue Sarcoma

Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery

FDA Grants Fast Tract Designation to VT3989 for Mesothelioma

© 2025 MJH Life Sciences^®

All rights reserved.